INFINITY BIOLOGIX LLC

INFINITY BIOLOGIX LLC specializes in advanced genomic sequencing and biotechnology research services, delivering end-to-end solutions for large-scale DNA analysis and genetic characterization. The company excels in whole genome sequencing, whole exome sequencing, and long-read sequencing technologies, supporting high-resolution genomic platforms used in precision medicine and population health studies. Their technical expertise includes next-generation sequencing (NGS) workflows, array-based genomic profiling, and bioinformatic analysis pipelines tailored for complex biological datasets, with demonstrated experience in SARS-CoV-2 variant tracking and national-scale genetic surveillance programs. A key differentiator is their ability to execute mission-critical sequencing operations under stringent federal requirements, ensuring data integrity and regulatory compliance without formal certifications. The contractor maintains a strong, sustained relationship with the Department of Veterans Affairs and the Department of Health and Human Services, providing genomic analysis and sequencing services for veteran health initiatives and national research programs such as the Genome Characterization Center and NIDA genetic studies. They also support the Department of Agriculture with targeted biotechnology research, indicating adaptability across public health and agricultural genomics domains. INFINITY BIOLOGIX operates primarily under NAICS 541380 (Testing Laboratories and Services) and 541714 (Biotechnology R&D), positioning itself as a niche provider of federal genomic infrastructure services. Their market focus is on government-funded biomedical research, infectious disease surveillance, and precision health initiatives requiring scalable, high-throughput sequencing capabilities. As a small business entity structured as 2K and headquartered in Piscataway, New Jersey, INFINITY BIOLOGIX LLC is strategically positioned to serve federal agencies requiring agile, technically sophisticated sequencing and biotech R&D support. While lacking formal government certifications, their consistent performance across high-stakes federal contracts underscores reliability and technical competence in a specialized, data-intensive domain.